Case Series and Literature Review of Ophthalmologic Disorders Seen in a Specialist Rheumatology Clinic in Lagos, Nigeria

References

• Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest. 2010;120(9):3073–3083. doi:10.1172/JCI42440.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Suhler E, Skup M, et al. Prevalence of noninfectious uveitis in the united states: a claims-based analysis. JAMA Ophthalmol. 2016;134(11):1237–1245. doi:10.1001/jamaophthalmol.2016.3229.
   PubMed Web of Science ®Google Scholar
• Foster C Ocular autoimmune disease: an introduction the ocular immunology and uveitis foundation; 2018. http://www.uveitis.org/patient_articles/ocular-autoimmune-disease-introduction/. Accessed October 1, 2019.
   Google Scholar
• Caspi RR. Ocular autoimmunity: the price of privilege? Immunol Rev. 2006;213(1):23–35. doi:10.1111/j.1600-065X.2006.00439.x.
   PubMedGoogle Scholar
• Mohsenin A, Huang JJ. Ocular manifestations of systemic inflammatory diseases. Connecticut Med. 2012;76:533–544.
   PubMedGoogle Scholar
• Chan W-M. Ophthalmologic manifestations of rheumatic diseases: a brief review. Hong Kong Bulletin on Rheumatic Diseases. 2004;4(2):60–69.
   Google Scholar
• Kwiatkowska B, Maślińska M. Eye infection complications in rheumatic diseases, Ch. 10. In: Chaudhry IA, ed. Common Eye Infections. Rijeka: InTech; 2013:213–230.
   Google Scholar
• Coles RS. Ocular manifestations of connective tissue disease. Hosp Pract. 1985;20:70–80.
   PubMed Web of Science ®Google Scholar
• Kraus CL, Culican SM. Use of biologic agents in ocular manifestations of rheumatic disease. Int J Rheumatol. 2012;1:1–5. doi:10.1155/2012/203819.
   Google Scholar
• Atkin SR. Ocular and systemic manifestations of the acquired connective tissue diseases: part I. Clin Eye Vision Care. 1996;8(2):67–84. doi:10.1016/0953-4431(96)00160-9.
   Google Scholar
• Ciurtin C, Cojocaru VM, Arama S, Stoica V. Epidemiology of ocular involvement in autoimmune diseases. Rom J Intern Med. 2008;46:243–247.
   PubMedGoogle Scholar
• Levitt AE, McManus KT, McClellan AL, Davis J, Goldhardt R, Galor A. Ocular inflammation in the setting of concomitant systemic autoimmune conditions in an older male population. Cornea. 2015;34(7):762. doi:10.1097/ICO.0000000000000437.
   PubMed Web of Science ®Google Scholar
• Tayel MY, Mohannad N, El Gerby AH, Amin RM. Prevalence and pattern of ocular involvement in patients attending Alexandria University rheumatology clinic: a pilot study. Int J. 2015;3:153–158.
   Google Scholar
• Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum. 2001;30(4):217–241. doi:10.1053/sarh.2001.16639.
   PubMed Web of Science ®Google Scholar
• Barry RJ, Nguyen QD, Lee RW, Murray PI, Denniston AK. Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol. 2014;8:1891–1911.
   PubMedGoogle Scholar
• Foster CS, Kothari S, Anesi SD, et al. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management. Surv Ophthalmol. 2016;61(1):1–17. doi:10.1016/j.survophthal.2015.07.001.
   PubMed Web of Science ®Google Scholar
• Amador-Patarroyo MJ, Cristina Penaranda A, Teresa Bernal M, et al. Autoimmune uveitis, Ch37. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, eds. Autoimmunity: From Bench to Bedside. Bogota (Colombia): El Rosario University Press; 2013:643–652.
   Google Scholar
• Dick AD, Rosenbaum JT, Al-Dhibi HA, et al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative. Ophthalmology. 2018;125(5):757–773. doi:10.1016/j.ophtha.2017.11.017.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Bachali A, Sahli H, Tekaya R, Mahmoud I, Hedhili S, Abdelmoula L. Analysis of referral letters to rheumatology consultation in Tunisia. Egypt Rheumatologist. 2017;39(3):179–182. doi:10.1016/j.ejr.2017.01.002.
   Web of Science ®Google Scholar
• Oguntona S, Adelowo O. Ocular manifestations of autoimmune diseases—review of literature. 2008. Niger J Ophthalmol. 2006;14(2):68–74. doi:10.4314/njo.v14i2.11988.
   Google Scholar
• Widdifield J, Tu K, Carter Thorne J, et al. Patterns of care among patients referred to rheumatologists in Ontario, Canada. Arthritis Care Res (Hoboken). 2017;69(1):104–114. doi:10.1002/acr.22910.
   PubMed Web of Science ®Google Scholar
• Domngang Noche C, Kagmeni G, Dohvoma V, Bella AL, Ebana Mvogo C, Singwe-Ngandeu M. Ophthalmic manifestations in chronic inflammatory rheumatic diseases at a referral hospital of Yaounde, Cameroon. Ocul Immunol Inflamm. 2016;26(2):259–264. doi:10.1080/09273948.2016.1212078.
   PubMed Web of Science ®Google Scholar
• Guilar J, Wamuo I, Choy EHS, Hossain M, Scott DL. Who is referred for specialist rheumatology care? Rheumatology. 2000;39:1292–1294.
   PubMed Web of Science ®Google Scholar
• Scheibe MM, Imboden JB, Schmajuk G, et al. Efficiency gains for rheumatology consultation using a novel electronic referral system in a safety-net health setting. Arthritis Care Res (Hoboken). 2015;67(8):1158–1163. doi:10.1002/acr.22559.
   PubMed Web of Science ®Google Scholar
• Ng X, Low AHL, Chew LC, et al. Disease patterns of rheumatology outpatients seen in a tertiary hospital serving a multi‐ethnic, urban Asian population in Singapore. Int J Rheum Dis. 2013;16(3):273–278. doi:10.1111/1756-185x.12016.
   PubMed Web of Science ®Google Scholar
• Schaftenaar E, Meenken C, Baarsma GS, et al. Uveitis is predominantly of infectious origin in a high HIV and TB prevalence setting in rural South Africa. British J Ophthalmol. 2016;100(101):312–316. doi:10.1136/bjophthalmol-2015-307157.
   PubMedGoogle Scholar
• Okonkwo ON, Adelowo OO, Hassan AO, Gyasi ME. Bilateral necrotizing sclero uveitis in a Nigerian: management and outcome. Int J Case Rep Imag. 2018;9:1–4.
   Google Scholar
• Akintayo RO, Adelowo OO, Egajifo O, et al. The impact of ocular manifestations of rheumatoid arthritis on the health-related quality of life and the functional ability of black Africans. Int Ophthalmol. 2018;1:1–10.
   Google Scholar
• Adelowo OO, Umar A. Juvenile idiopathic arthritis among Nigerians: a case study. Clin Rheumatol. 2010;29(7):757–761. doi:10.1007/s10067-010-1401-y.
   PubMed Web of Science ®Google Scholar
• Ajose FO, Adelowo O, Oderinlo O. Clinical presentations of Behçet‘s disease among Nigerians: a 4‐year prospective study. Int J Dermatol. 2015;54(8):889–897. doi:10.1111/ijd.12554.
   PubMed Web of Science ®Google Scholar
• Prete M, Guerriero S, Dammacco R, et al. Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center. J Ophthalmic Inflamm Infect. 2014;4(1):17. doi:10.1186/s12348-014-0017-9.
   PubMedGoogle Scholar
• Charkoudian LD, Ying G-S, Pujari SS, et al. High-dose intravenous corticosteroids for ocular inflammatory diseases. Ocul Immunol Inflamm. 2012;20(2):91–99. doi:10.3109/09273948.2011.646382.
   PubMed Web of Science ®Google Scholar
• Gangaputra S, Newcomb CW, Liesegang TL, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116(11):2188–2198. doi:10.1016/j.ophtha.2009.04.020.
   PubMed Web of Science ®Google Scholar
• Olivieri I, Accorinti M, Abicca I, et al. Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement. Rheumatol Int. 2018;38(9):1727–1734. doi:10.1007/s00296-018-4094-1.
   PubMed Web of Science ®Google Scholar